SCHEMBL279092

SCHEMBL279092

C=C(/N=C/c1cc(Br)ccc1Oc1ccc(C(=O)OC)cc1Cl)O[Si](C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR5 P51681 2/20 0.41
MAPT P10636 8/20 0.39
KDM4E B2RXH2 6/20 0.38
ALDH1A1 P00352 3/20 0.38
GFER P55789 1/20 0.38
KMT2A Q03164 8/20 0.38
MEN1 O00255 4/20 0.38
CYP3A4 P08684 1/20 0.38
ESRRA P11474 1/20 0.38
SMN1; SMN2 Q16637 5/20 0.37
LMNA P02545 4/20 0.37
NPC1 O15118 6/20 0.37
RAB9A P51151 6/20 0.37
KLF5 Q13887 2/20 0.37
HTT P42858 2/20 0.36
GAA P10253 1/20 0.36
MITF O75030 1/20 0.36
PKM P14618 2/20 0.35
POLB P06746 1/20 0.35
MMP2 P08253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL279086 0.89 MAPT (0.49) CCR5MAPTKDM4EALDH1A1KMT2A
SCHEMBL278988 0.87 CCR5 (0.45) CCR5MAPTKDM4EALDH1A1KMT2A
SCHEMBL278999 0.79 ALDH1A1 (0.39) MAPTKDM4EALDH1A1KMT2AMEN1
SCHEMBL275650 0.79 CYP3A4 (0.45) CCR5MAPTKDM4EALDH1A1KMT2A
SCHEMBL278990 0.77 LMNA (0.39) CCR5MAPTKDM4EALDH1A1KMT2A
SCHEMBL279335 0.75 CA1 (0.36) CCR5MAPTKDM4EALDH1A1KMT2A
SCHEMBL278939 0.73 LMNA (0.41) CCR5MAPTKDM4EALDH1A1KMT2A
SCHEMBL279339 0.73 LMNA (0.40) CCR5MAPTKDM4EALDH1A1KMT2A
SCHEMBL275218 0.71 HPGD (0.41) CCR5MAPTKDM4EALDH1A1KMT2A
SCHEMBL279344 0.71 SLC6A4 (0.46) MAPTKDM4EALDH1A1KMT2ACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8134001-B2 Spiroindolinone derivatives HOFFMANN-LA ROCHE INC. (US) 2012-03-13 US disclosed
US-20090156610-A1 Spiroindolinone Derivatives DING QINGJIE 2009-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156610-A1 Spiroindolinone Derivatives SDHA, AR, XPOT CCR5 2331/4885MAPT 4062/4885KDM4E 2534/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.